2023 annual financial data
Quince Therapeutics 2023 Operating margin
Quince Therapeutics 2023 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -34,620,000 USD and net income was -31,385,000 USD.
Operating cash flow was -18,292,000 USD.
Get free Quince Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -34,620,000 USD
- Net income
- -31,385,000 USD
- Operating cash flow
- -18,292,000 USD